Spinout Active LTD

Company profile

Pragmatic Genomics Limited

Pragmatic Genomics Ltd

Pragmatic Genomics Limited is a spin-off of Queen Mary University of London. We provide software and analysis services to genomics researchers and clinical geneticists working in biomedical, agricultural and environmental organizations.

CRN
13539725
Founded
2021
Age
4

Overview

Browse spinouts
Legal name
PRAGMATIC GENOMICS LIMITED
Region
Unknown
Registered address
C/O QUEEN MARY INNOVATION QMB INNOVATION CENTRE
42 NEW ROAD
LONDON (WHITECHAPEL)
ENGLAND
E1 2AX
Insolvency history
No

Latest accounts

Financial period: 1 Dec 2023 to 30 Nov 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
0

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Aug
2026

Accounts due

Accounts Due

Next accounts due date

12 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

29 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Nov
2024

Accounts filed

Accounts

Last accounts made up date

30 Jul
2021

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Pragmatic Genomics develops a range of data science software and provides data analysis, specialising in genomics data.

Software as a service company - for our bioinformatics genome analysis software

Project impact

Customers in private (biotech, agroindustry), public and third sectors.

Pragmatic Genomics
2021
Pragmatic Genomics
2021
Pragmatic Genomics
2021
PRAGMATIC GENOMICS LIMITED
2021

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
1 years

Projects

2023 Grant for R&D Lead participant

Transforming SequenceServer: unlocking new revenue opportunities by incorporating collaborative tools and molecular cloning capabilities

1 Jun 2023 to 30 Nov 2023

Awarded
£49,972
Total cost £49,972

The commoditisation and decentralisation of DNA sequencing has completely changed biological research, with similar changes underway in biological engineering across agroindustry, biotech, pharma, diagnostics and treatment of disease. A key challenge that accompanies the resulting opportunities is for staff scientists to make sense of the spectacular amou...

Product types

Grant for R&D